Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CLIA
Veridien Climate Action ETF
$18.61
-0.2%		$18.61
$16.48
▼
$21.28
$23.45M1.349,925 shs75,500 shs
PPIE
Putnam PanAgora ESG International Equity ETF
$26.85
+1.4%		$26.47
$24.63
▼
$29.52
$4.03M0.6683,179 shs5 shs
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
$33.14
+1.0%		$31.92
$22.44
▼
$33.54
$3.98M0.522,631 shs86,829 shs
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
$24.76
+0.3%		$24.66
$20.98
▼
$27.28
$4.21M0.42,133 shs716 shs
Elon Musk's Next Move Cover
Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CLIA
Veridien Climate Action ETF
0.00%0.00%0.00%0.00%0.00%
PPIE
Putnam PanAgora ESG International Equity ETF
-0.22%+0.98%+3.31%-5.02%+6.08%
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
-0.84%+0.03%+1.97%+11.25%+44.40%
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
+0.53%+3.55%-0.56%-4.66%+11.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CLIA
Veridien Climate Action ETF
$18.61
-0.2%		$18.61
$16.48
▼
$21.28
$23.45M1.349,925 shs75,500 shs
PPIE
Putnam PanAgora ESG International Equity ETF
$26.85
+1.4%		$26.47
$24.63
▼
$29.52
$4.03M0.6683,179 shs5 shs
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
$33.14
+1.0%		$31.92
$22.44
▼
$33.54
$3.98M0.522,631 shs86,829 shs
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
$24.76
+0.3%		$24.66
$20.98
▼
$27.28
$4.21M0.42,133 shs716 shs
Elon Musk's Next Move Cover
Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CLIA
Veridien Climate Action ETF
0.00%0.00%0.00%0.00%0.00%
PPIE
Putnam PanAgora ESG International Equity ETF
-0.22%+0.98%+3.31%-5.02%+6.08%
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
-0.84%+0.03%+1.97%+11.25%+44.40%
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
+0.53%+3.55%-0.56%-4.66%+11.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CLIA
Veridien Climate Action ETF
2.47
Hold$18.61N/A
PPIE
Putnam PanAgora ESG International Equity ETF
2.66
Moderate Buy$26.85N/A
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
2.79
Moderate Buy$33.14N/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
2.60
Moderate Buy$24.76N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CLIA
Veridien Climate Action ETF
N/AN/AN/AN/AN/AN/A
PPIE
Putnam PanAgora ESG International Equity ETF
N/AN/AN/AN/AN/AN/A
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
N/AN/AN/AN/AN/AN/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CLIA
Veridien Climate Action ETF
N/AN/A16.68N/AN/AN/AN/AN/AN/A
PPIE
Putnam PanAgora ESG International Equity ETF
N/AN/A14.65N/AN/AN/AN/AN/AN/A
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
N/AN/A13.55N/AN/AN/AN/AN/AN/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
N/AN/A24.31N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CLIA
Veridien Climate Action ETF
N/AN/AN/AN/AN/A
PPIE
Putnam PanAgora ESG International Equity ETF
$1.124.23%N/AN/AN/A
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
$0.611.83%N/AN/AN/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
$0.220.89%N/AN/AN/A

Latest THNR, CLIA, PPIE, and RNWZ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/19/2026
PPIE
Putnam PanAgora ESG International Equity ETF
$1.12202/20/20262/20/20263/2/2026
(Data available from 1/1/2013 forward)

Institutional Ownership

CompanyInstitutional Ownership
CLIA
Veridien Climate Action ETF
N/A
PPIE
Putnam PanAgora ESG International Equity ETF
N/A
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
N/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
N/A

Insider Ownership

CompanyInsider Ownership
CLIA
Veridien Climate Action ETF
N/A
PPIE
Putnam PanAgora ESG International Equity ETF
N/A
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
N/A
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
CLIA
Veridien Climate Action ETF
N/A1.26 millionN/ANot Optionable
PPIE
Putnam PanAgora ESG International Equity ETF
N/A150,000N/ANot Optionable
RNWZ
TrueShares Eagle Global Renewable Energy Income ETF
N/A120,000N/ANot Optionable
Amplify Weight Loss Drug & Treatment ETF stock logo
THNR
Amplify Weight Loss Drug & Treatment ETF
N/A170,000N/AN/A

Recent News About These Companies

A gloved hand holds a GLP-1 agonist injection pen in a laboratory setting.
3 Ways to Invest in the Growing GLP-1 Weight Loss Market (THNR)
...
April 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/stock-ideas/3-ways-to-invest-in-the-growing-glp-1-weight-loss-market/
Weight Loss ETF THNR Reweights Its Index: What's Up & Down
March 25, 2026  |  etftrends.comE
Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) Short Interest Update
March 13, 2026  |  defenseworld.netD
ETFs tied to HIMS gain attention as the telehealth stock spikes
March 9, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/etfs-tied-to-hims-gain-attention-as-the-telehealth-stock-spikes/ar-AA1XPuL3
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook
February 4, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2828794/healthcare-etfs-to-watch-as-novo-nordisk-tumbles-on-poor-sales-outlook?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2828794
New Year, New Strategy: Navigating Weight Loss ETFs
January 12, 2026  |  etftrends.comE
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs
September 18, 2025  |  benzinga.comhttps://www.benzinga.com/etfs/sector-etfs/25/09/47744073/hims-hers-eli-lilly-novo-nordisk-face-fda-scrutiny-what-it-means-for-weight-loss-etfs?utm_source=snapi
Weight Loss Drug ETF (THNR) Hits New 52-Week High
June 2, 2025  |  zacks.comhttps://www.zacks.com/stock/news/2480003/weight-loss-drug-etf-thnr-hits-new-52-week-high?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2480003
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs
January 17, 2025  |  etftrends.comE
Disruptive Theme of the Week – Breakthroughs in Medicine
November 21, 2024  |  etftrends.comE
Amplify ETFs Hits $10 Billion in Assets Amid New ETF Launches
October 29, 2024  |  etftrends.comE
Tap the Weight-Loss Drug Market With These ETFs
September 18, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2337974/tap-the-weight-loss-drug-market-with-these-etfs?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2337974
Disruptive Theme of the Week: Playing Defense
August 14, 2024  |  etftrends.comE
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment
July 22, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2306321/etfs-in-focus-as-competition-heats-up-in-weight-loss-drug-segment?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2306321
Top Themes in the First Half of 2024: Crypto, Chips, Ships & Silver
July 2, 2024  |  etftrends.comE
Why Investors Haven't Feasted on Two New Weight-Loss ETFs
June 24, 2024  |  investopedia.comhttps://www.investopedia.com/why-investors-have-not-feasted-on-two-new-weight-loss-etfs-8668085
Finding Opportunity in Unloved Healthcare ETFs
May 31, 2024  |  etftrends.comE
Play These New ETFs to Tap Lucrative Weight Loss Drug Market
May 22, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2277076/play-these-new-etfs-to-tap-lucrative-weight-loss-drug-market?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2277076

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Nike logo positioned in front of a running shoe, highlighting product strength.
With Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?
By Sam Quirke | April 12, 2026
Close-up of U.S. dollar bills with “dividends” label and growing coin stacks.
3 Dividend Aristocrats Whose Yields Can Help Combat Inflation
By Chris Markoch | April 9, 2026
Military tank amid conflict backdrop with rising candlestick chart, tied to C, VZ, and DAL post-war recovery potential.
The War Won't Last Forever: 3 Stocks That Could Lead the Recovery
By Bridget Bennett | April 8, 2026
Red sale tag hanging from clothing, symbolizing stocks at discounted valuations.
3 Discounted Stocks With Strong Rebound Potential
By Chris Markoch | April 6, 2026
A gloved hand holds a GLP-1 agonist injection pen in a laboratory setting.
3 Ways to Invest in the Growing GLP-1 Weight Loss Market
By Nathan Reiff | April 17, 2026

Veridien Climate Action ETF NYSEARCA:CLIA

$18.61 -0.04 (-0.21%)
As of 08/16/2024

The Veridien Climate Action ETF (CLIA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed, non-transparent ETF that seeks to invest in companies, via US-listed stocks or ADRs from around the world, that are considered to be making a substantial contribution to mitigating climate change. The fund utilizes the Precidian non-transparent model CLIA was launched on May 8, 2023 and is managed by Veridien.

Putnam PanAgora ESG International Equity ETF NYSEARCA:PPIE

$26.85 +0.38 (+1.44%)
As of 05/5/2026 04:10 PM Eastern

The Putnam Panagora ESG International Equity ETF (PPIE) is an exchange-traded fund that mostly invests in total market equity. The fund actively invests in developed international companies of any capitalization, excluding the US. Selected companies are perceived to possess positive environmental, social, and governance criteria. PPIE was launched on Jan 19, 2023 and is managed by Putnam.

TrueShares Eagle Global Renewable Energy Income ETF NYSEARCA:RNWZ

$33.14 +0.33 (+1.01%)
As of 05/5/2026 04:10 PM Eastern

The TrueShares Eagle Global Renewable Energy Income ETF (RNWZ) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund seeks long-term capital growth by actively managing a portfolio of renewable energy infrastructure companies from across the globe. RNWZ was launched on Dec 8, 2022 and is managed by TrueShares.

Amplify Weight Loss Drug & Treatment ETF stock logo

Amplify Weight Loss Drug & Treatment ETF NYSEARCA:THNR

$24.76 +0.08 (+0.32%)
As of 05/5/2026 04:10 PM Eastern

The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas